🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So excited for the inaugural fellow’s meeting of #ASCENDHF ! Shelley Hall Alexander Hajduczok, MD 🇺🇦🙏 @CVRx_Inc Let’s continue to focus on trainees and the opportunities for a career in HF‼️

Baroreflex Function in Cardiovascular Disease - Journal of Cardiac Failure onlinejcf.com/article/S1071-… Way to go SWIFT-HF!! Marat Fudim, MD MHS Richa Gupta Dmitry Yaranov Pujan Patel, MD @CVRx_Inc Vishal Rao Amin Yehya, MD, MS, FACC, FHFSA @AlbertHicksMD kmasser Paul Verrastro Andrew Ganton

It is World Thrombosis Day! instagram.com/reel/DBB69Sqhy…

Today we announced our third quarter results and provided a business outlook for the rest of 2024. We are pleased to share these milestones: -Active US implanting centers increased 31% over prior year Q3 -US HF revenue increased 30% over prior year Q3 -Increased worldwide

We are pleased to announce that the Centers for Medicare and Medicaid (CMS) assigned the Barostim implant procedure to New Technology Ambulatory Payment Classification (APC) 1580. “We applaud this action by CMS, which appropriately recognizes the resource requirements

CMS updates outpatient reimbursement policy for implantable Barostim device @CVRx_Inc #cardiology #cardiotwitter ow.ly/oXOT50U0EEV

Join our upcoming webinar with MedAxiom to learn how #Barostim, a novel device therapy, targets neurohormonal pathways to improve #heartfailure symptoms. 📅 Date: Tuesday, Nov. 19, 1:00 PM EST 👨‍⚕️ Guest Faculty: Bonnie Handke, RN, MBA, Jim Kreiner, MHA, and Patrick McCann, MD

It’s been quite a journey ♥️. Thanks to Inari Medical and MGH for saving my life. youtu.be/ORy5OvvTo6w?si…

linkedin.com/posts/cvrx_hea…

Anyone know this third year cardiology fellow Dr Freire? What an unbelievable story!!!

Today we announced our preliminary Q4 and 2024 financial results and provided a business outlook for 2025. We are pleased to share these milestones: -2024 Q4 revenue expected to be $15.2M to $15.3M, representing 35% growth -2024 revenue expected to be $51.1M to $51.2M,

Mark your calendars January 23rd we are bringing forward the talks we planned to give in Atlanta HFSA prior to hurricane cancellations. Marat Fudim, MD MHS Liviu Klein Shelley Hall Heart Failure Seminar: Devices in Heart Failure Meeting: From Mechanisms to Implementation | HFSA

For some patients with #HeartFailure, medications and devices like a pacemaker may not relieve symptoms or slow disease progression. Learn from Richa Gupta about how a device called Barostim gives these patients an effective, innovative treatment option. medstarhealth.org/blog/barostim-…

🆕 #ACCEd: Baroreflex Activation Therapy (BAT): Optimizing Treatment of HF This course covers the stages of #HeartFailure where BAT is effective, including its benefits & limitations for early intervention. 👇 Check out the infographic & learn more: bit.ly/3FhEoMO

Increasing Access: Reducing Referral Delay in ambulatory advanced HF Patients - Journal of Cardiac Failure onlinejcf.com/article/S1071-…

Goodnight Moon: The (not so) mystical effect of folklore and superstitions on cardiac transplantation - The Journal of Heart and Lung Transplantation jhltonline.org/article/S1053-…

Congratulations to the ASCEND fellows! Thank you to the faculty who participated and shared their wisdom and experience over the last three programs. A special thanks to ⁦Shelley Hall⁩ ⁦Jeff Teuteberg⁩ and ⁦Alexander Hajduczok, MD 🇺🇦🙏⁩ for their passion and leadership! ⁦

🚨ASCEND v2.0‼️ Pleasure to be co-directing with Shelley Hall Alexander Hajduczok, MD 🇺🇦🙏 & Merna Hussein for CVRx | Barostim's next course for 2nd & 3rd year gen cards or HF fellows. Reach out & apply! Save 📅: 10/10-12, 2025 Minneapolis 5/15-17, 2026 Dallas + 5 case-based virtual meetings

Check our latest work on device therapies in patients with #HFrEF. Dmitry Yaranov Marat Fudim, MD MHS Nirav Raval kmasser Richa Gupta Pujan Patel, MD Amit Alam Angela Reinke Vikram Raje Vishal Rao EVMS Medicine #CardioTwitter #MedEd #SoMe

What are the top HFpEF papers of the year to Ryan J Tedford MD? Excluding the obvious contenders, he honed in the following points: ⛔️ PAH drugs not indicated in HFpEF PAH ⚡️Attention to autonomic dysfunction and preload failure in HFpEF 🆕 Promising new therapies #charlestonhfpef